# SEG Drug HTML Closure Decision v1

**Mode:** `CONTROLLED EVIDENCE CLOSURE EXECUTION`  
**Scope:** Drug HTML source candidate only; evidence closure and disposition review without normalization or production integration.  
**Prepared by:** **Manus AI**  
**Final source decision:** `BLOCKED_PENDING_EVIDENCE`

## 1. Control Boundary

This decision records the closure state supported by the current SEG project evidence. A recovered HTML artifact, checksum, structural observation, or entity count is not treated as proof of canonical publication identity, medical correctness, rights, provenance, or approval. No source approval is issued by this report.

The artifact remains a retained internal reference representation. It must not be converted into a governed medication database, content record, learner-facing material, or normalized source without a later approval decision for the exact representation.

## 2. Source Identity Closure

| Required item | Evidence currently available | Status |
|---|---|---|
| Original source title | The project records a recovered static HTML artifact referred to as the Drug HTML candidate; no authoritative publication title is established | `PARTIALLY_CONFIRMED` |
| Original publisher/owner | No attributable publisher or owner evidence is recorded in the available closure materials | `NOT_AVAILABLE` |
| Authoring organization | Not established | `NOT_AVAILABLE` |
| Version/edition | No authoritative version or edition is established | `NOT_AVAILABLE` |
| Publication date | No authoritative publication date is established | `NOT_AVAILABLE` |
| Original source location | No verified original URL, repository, release, or other locator is established | `NOT_AVAILABLE` |
| Artifact identity as retained local representation | Recovered HTML artifact continuity, checksum, and structural/entity observations are recorded | `PARTIALLY_CONFIRMED` |

**Identity gate:** `PARTIALLY_CONFIRMED`. The available evidence identifies a retained representation, not the authoritative source behind it.

## 3. Provenance Closure

| Provenance requirement | Current evidence | Status |
|---|---|---|
| Artifact origin | Local recovered static HTML artifact is recorded; originating publication or export event is not independently attributable | `PARTIALLY_CONFIRMED` |
| Recovery history | Recovery and artifact continuity observations are recorded in the SEG recovery materials | `PARTIALLY_CONFIRMED` |
| Transformation history | No complete record of export, scraping, conversion, translation, rewrite, or other transformation is available | `NOT_AVAILABLE` |
| Chain of custody | Local retention is recorded, but the complete original source → extraction → recovery artifact → registry chain is not closed | `PARTIALLY_CONFIRMED` |
| Exact artifact-to-source locator relationship | Not established | `NOT_AVAILABLE` |

**Provenance gate:** `PARTIALLY_CONFIRMED`. Recovery continuity does not close authoritative provenance.

## 4. Rights and License Closure

| Rights requirement | Current evidence | Status |
|---|---|---|
| Copyright owner | Not established | `NOT_AVAILABLE` |
| Educational-use permission | No attributable permission is recorded | `NOT_AVAILABLE` |
| Redistribution permission | No permission or license allowing redistribution is recorded | `NOT_AVAILABLE` |
| License status | No verified license is recorded for the HTML or its underlying content | `NOT_AVAILABLE` |
| Restrictions and publication limitations | Not established | `NOT_AVAILABLE` |

**Rights gate:** `NOT_AVAILABLE`. The recovered artifact cannot be redistributed, published, or exposed to learners on the current evidence.

## 5. Medical and Technical Review Gates

### 5.1 Medical review

**Required reviewer role:** Emergency Medicine medication-safety reviewer, with clinical pharmacology or equivalent medication expertise where assigned by governance.

**Review scope:** The exact retained HTML representation must be reviewed for drug identity, dose statements, interactions, contraindications, indications, omissions, ambiguity, and conflicts. Structural entity counts are not clinical validation.

**Current status:** `PENDING`. No completed, attributable review decision for the exact artifact is recorded.

### 5.2 Technical review

**Required reviewer role:** Technical reviewer for HTML representation integrity and evidence reproducibility.

**Review scope:** Verify the retained artifact, rendering/encoding integrity, extraction boundaries, stable locators, and reproducibility of any evidence used for later review. This does not authorize application integration.

**Current status:** `PENDING`.

### 5.3 Visual and accessibility review

The current closure scope concerns a recovered static HTML representation. Visual and accessibility review is not a substitute for source identity, rights, provenance, or medical review. If the representation is later proposed for a learner-facing interface, a separate visual and accessibility review must be queued before publication.

## 6. Missing Evidence and Blocking Reasons

The source remains blocked because canonical title, owner, version/date, original locator, transformation history, complete provenance, copyright/permission evidence, and exact-artifact medical and technical reviews are unresolved. The artifact must also remain separate from any approved medication content structure; no medication facts are promoted from the recovered representation by this report.

## 7. Allowed Next Action

Request attributable external identity, rights, and provenance evidence for the exact artifact or its authoritative source. Preserve the HTML unchanged, record the evidence locator and custody, and then queue the exact representation for role-based medication-safety and technical review. The next action is evidence acquisition and review preparation only.

## 8. Final Decision

```text
SOURCE = Drug HTML
FINAL_DECISION = BLOCKED_PENDING_EVIDENCE
APPROVED_FOR_NORMALIZATION = NO
INTERNAL_REFERENCE_ONLY = YES
```

This is not an approval, not a normalization authorization, and not a decision to import or publish the artifact.

## 9. Prohibited Actions

The following remain prohibited: normalization, extraction into chapters or content records, Zod or Prisma work, SQL, migrations, imports, activation, publication, learner exposure, database changes, application changes, and any change to Source Registry approval states.

## References

[1]: file:///home/ubuntu/seg-internship-output/SEG_EXTERNAL_EVIDENCE_COLLECTION_REPORT_v1.md "SEG External Evidence Collection Report v1"
[2]: file:///home/ubuntu/seg-internship-output/SEG_SOURCE_CLOSURE_DECISION_QUEUE.md "SEG Source Closure Decision Queue"
[3]: file:///home/ubuntu/seg-internship-output/SEG_EXTERNAL_EVIDENCE_ACQUISITION_TRACKER.md "SEG External Evidence Acquisition Tracker"

---

**SEG_DRUG_HTML_CLOSURE_DECISION_v1**
